Although there are no regulatory requirements or established pharmacopoeial techniques for the dissolution testing of inhaled drugs, such testing can potentially open up the opportunity to tailor ...
New York, NY, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Pharmaceutical Dissolution Testing Services Market Share, Size, Trends, Industry ...
Dissolution testing is an important aspect of drug development as it provides stability parameters and helps predict drug behavior in-vivo. For solid oral dosage forms, dissolution testing is a ...
In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...
The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...
The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback